CYP2D6/tramadol Pharmacogenomic Lab Test
The CYP2D6 genetic test is used to predict how you will respond to a large number of different medications.
Routine testing for tramadol and CYP2D6 is usually not done. You may have had the CYP2D6 test done for other reasons.
Your CYP2D6 result may have different recommendations based on the specific medications you are prescribed.
CYP2D6 test results and tramadol
What should I do with my test results?
Talk to your health care provider or pharmacist about the results. They may suggest that you:
- Keep taking a medication
- Change the dose of a medication
- Stop taking a medication
- Take a different medication
What does my CYP2D6 result mean if I’m taking tramadol?
Your body processes (metabolizes) tramadol poorly to the more active form. Talk with your healthcare provider about choosing a medication that may be a better option for you.
|Poor to Intermediate Metabolizer|
Your body processes tramadol at a normal rate. A standard dose will generally be suggested.
|Intermediate to Extensive Metabolizer|
|Intermediate to Ultra Rapid Metabolizer||
There are two possibilities with this test result. Your body may process (metabolize) tramadol differently, which may result in side effects. Talk with your health care provider about choosing a medication that may be a better option for you.
|Extensive to Ultra Rapid Metabolizer|
|Ultra Rapid Metabolizer||
Your body has an increased ability to process (metabolizes) tramadol to the more active form, which may result in side effects. Talk with your healthcare provider about choosing a medication may be a better option for you.
Who will see my results?
Only health care professionals, and those you have given permission, may view your genetic test results. If you are receiving care at another medical facility, we suggest you share this information with your other health care providers.
How could the CYP2D6 test result affect my treatment with tramadol?
Your health care provider may suggest you take a different pain medication.
Who is affected? Do different populations respond differently?
Genetic variation in CYP2D6 is dependent on ethnic background. People from Saudi Arabia and Ethiopia are more likely to process tramadol quickly, whereas Caucasians are more often found to process tramadol slowly.
Routine testing for tramadol and CYP2D6 is not recommended.
You only need to have CYP2D6 genetic testing one time.
What is tramadol?
Tramadol is a medication used for moderate or moderately severe pain relief, including pain following surgery.
Which gene affects my response to tramadol?
Variants in the CYP2D6 gene influence the way your body processes (metabolizes) tramadol and can affect your response to this medication.
What problems can patients with the CYP2D6 variants have when taking tramadol?
Patients who have a CYP2D6 variant that metabolizes tramadol quickly may experience side effects such as nausea, vomiting, constipation, difficulty urinating, drowsiness, decreased mental alertness, and a reduced urge to breathe.
Patients who have a CYP2D6 variant that metabolizes tramadol slowly may have poor pain control.
Where can I find more information on tramadol?
More information about tramadol you might find helpful includes:
These resources may help you understand more about individualized medicine, genomics and drug-gene testing (pharmacogenomics):
- Mayo Clinic Center for Individualized Medicine
- Cytochrome P450 (CYP450) tests
- Frequently Asked Questions About Pharmacogenomics from National Institutes of Health (NIH) National Human Genome Research Institute
- Table of Pharmacogenomic Biomarkers in Drug Labeling from the U.S. Food and Drug Administration (FDA)
- Genetic Information Nondiscrimination Act (GINA)
- eMERGE Network: Electronic Medical Records and Genomics
- MyResults.org: Test Results
If you have questions about your test results, ask to speak with your health care provider at your Mayo Clinic care location: